Concepts (212)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus | 9 | 2024 | 146 | 2.340 |
Why?
|
| Hypertension | 12 | 2025 | 419 | 1.920 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2025 | 139 | 1.330 |
Why?
|
| Middle Aged | 35 | 2025 | 3601 | 1.120 |
Why?
|
| Humans | 54 | 2025 | 14537 | 1.030 |
Why?
|
| Cardiovascular Diseases | 8 | 2023 | 237 | 1.030 |
Why?
|
| Rural Population | 16 | 2022 | 654 | 1.030 |
Why?
|
| Cross-Sectional Studies | 20 | 2025 | 1422 | 1.020 |
Why?
|
| Female | 45 | 2025 | 9103 | 1.000 |
Why?
|
| Genome-Wide Association Study | 2 | 2025 | 106 | 0.970 |
Why?
|
| Male | 39 | 2025 | 6754 | 0.950 |
Why?
|
| Noncommunicable Diseases | 2 | 2024 | 77 | 0.910 |
Why?
|
| Thyrotropin | 1 | 2025 | 5 | 0.910 |
Why?
|
| Adult | 34 | 2025 | 5913 | 0.910 |
Why?
|
| Risk Factors | 20 | 2025 | 1475 | 0.890 |
Why?
|
| Multimorbidity | 3 | 2023 | 42 | 0.890 |
Why?
|
| Gene Frequency | 1 | 2025 | 122 | 0.880 |
Why?
|
| Hyperglycemia | 2 | 2021 | 15 | 0.860 |
Why?
|
| Prevalence | 18 | 2025 | 1192 | 0.830 |
Why?
|
| Aged | 27 | 2025 | 1740 | 0.810 |
Why?
|
| Dyslipidemias | 5 | 2025 | 57 | 0.780 |
Why?
|
| Africa South of the Sahara | 10 | 2025 | 353 | 0.690 |
Why?
|
| HIV Infections | 11 | 2024 | 5097 | 0.680 |
Why?
|
| Calcinosis | 2 | 2010 | 11 | 0.660 |
Why?
|
| Coronary Artery Disease | 2 | 2010 | 30 | 0.640 |
Why?
|
| Obesity | 7 | 2025 | 367 | 0.630 |
Why?
|
| South Africa | 29 | 2025 | 7596 | 0.500 |
Why?
|
| Blood Pressure | 7 | 2025 | 317 | 0.480 |
Why?
|
| Longitudinal Studies | 12 | 2025 | 435 | 0.450 |
Why?
|
| Blood Glucose | 4 | 2023 | 107 | 0.430 |
Why?
|
| Body Mass Index | 7 | 2025 | 321 | 0.430 |
Why?
|
| Sodium, Dietary | 2 | 2025 | 14 | 0.420 |
Why?
|
| Rural Health Services | 3 | 2017 | 48 | 0.400 |
Why?
|
| Osteoporosis | 2 | 2023 | 14 | 0.380 |
Why?
|
| Growth Hormone-Secreting Pituitary Adenoma | 1 | 2011 | 1 | 0.350 |
Why?
|
| Adenoma | 1 | 2011 | 4 | 0.350 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2022 | 21 | 0.350 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2011 | 5 | 0.350 |
Why?
|
| Microbiota | 2 | 2022 | 30 | 0.350 |
Why?
|
| Frailty | 2 | 2021 | 15 | 0.320 |
Why?
|
| Cohort Studies | 6 | 2021 | 967 | 0.300 |
Why?
|
| Metabolic Diseases | 2 | 2019 | 30 | 0.290 |
Why?
|
| Cognition | 2 | 2019 | 75 | 0.290 |
Why?
|
| Aging | 4 | 2021 | 109 | 0.280 |
Why?
|
| Sodium | 2 | 2025 | 30 | 0.270 |
Why?
|
| Sodium Chloride, Dietary | 2 | 2025 | 27 | 0.270 |
Why?
|
| Awareness | 2 | 2017 | 18 | 0.270 |
Why?
|
| Overweight | 2 | 2018 | 87 | 0.260 |
Why?
|
| Phenotype | 2 | 2025 | 158 | 0.260 |
Why?
|
| African Americans | 2 | 2021 | 47 | 0.260 |
Why?
|
| Atherosclerosis | 2 | 2021 | 100 | 0.250 |
Why?
|
| Sex Factors | 4 | 2023 | 227 | 0.250 |
Why?
|
| Carotid Intima-Media Thickness | 3 | 2023 | 108 | 0.240 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2025 | 8 | 0.230 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2025 | 3 | 0.230 |
Why?
|
| Frail Elderly | 3 | 2021 | 15 | 0.230 |
Why?
|
| Insulin-Secreting Cells | 1 | 2024 | 6 | 0.220 |
Why?
|
| Extracellular Vesicles | 1 | 2024 | 5 | 0.220 |
Why?
|
| Placenta | 1 | 2024 | 44 | 0.220 |
Why?
|
| Insulin | 1 | 2024 | 73 | 0.220 |
Why?
|
| Diabetes, Gestational | 1 | 2024 | 38 | 0.210 |
Why?
|
| Peripheral Arterial Disease | 1 | 2023 | 8 | 0.210 |
Why?
|
| Socioeconomic Factors | 4 | 2018 | 411 | 0.210 |
Why?
|
| Glycated Hemoglobin A | 2 | 2021 | 24 | 0.210 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2025 | 198 | 0.210 |
Why?
|
| Racism | 1 | 2023 | 4 | 0.200 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2023 | 11 | 0.200 |
Why?
|
| Epidemics | 1 | 2024 | 65 | 0.200 |
Why?
|
| Postmenopause | 1 | 2023 | 11 | 0.200 |
Why?
|
| Self Report | 2 | 2020 | 114 | 0.190 |
Why?
|
| Urinalysis | 1 | 2022 | 15 | 0.190 |
Why?
|
| Disabled Persons | 1 | 2023 | 23 | 0.190 |
Why?
|
| Life Style | 2 | 2020 | 86 | 0.190 |
Why?
|
| Sarcopenia | 1 | 2021 | 7 | 0.180 |
Why?
|
| Barbados | 1 | 2021 | 1 | 0.180 |
Why?
|
| Fasting | 1 | 2021 | 16 | 0.180 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 468 | 0.170 |
Why?
|
| Geography | 2 | 2018 | 60 | 0.170 |
Why?
|
| Sex Distribution | 2 | 2018 | 89 | 0.170 |
Why?
|
| Iohexol | 1 | 2020 | 7 | 0.160 |
Why?
|
| Cost-Benefit Analysis | 3 | 2024 | 253 | 0.160 |
Why?
|
| Exercise | 2 | 2020 | 205 | 0.160 |
Why?
|
| Adiposity | 1 | 2021 | 96 | 0.160 |
Why?
|
| Glomerular Filtration Rate | 1 | 2020 | 62 | 0.160 |
Why?
|
| Health Status Disparities | 1 | 2019 | 35 | 0.160 |
Why?
|
| Kidney Diseases | 1 | 2019 | 38 | 0.160 |
Why?
|
| Population Surveillance | 2 | 2018 | 325 | 0.150 |
Why?
|
| Autopsy | 1 | 2019 | 140 | 0.150 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 69 | 0.150 |
Why?
|
| Alcohol Drinking | 1 | 2019 | 55 | 0.150 |
Why?
|
| Smoking | 1 | 2019 | 100 | 0.150 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2019 | 256 | 0.150 |
Why?
|
| Continuity of Patient Care | 1 | 2018 | 33 | 0.140 |
Why?
|
| Cause of Death | 1 | 2019 | 221 | 0.140 |
Why?
|
| Physical Fitness | 1 | 2018 | 10 | 0.140 |
Why?
|
| Gene-Environment Interaction | 1 | 2018 | 12 | 0.140 |
Why?
|
| Hemoglobins | 1 | 2018 | 40 | 0.140 |
Why?
|
| Urban Population | 1 | 2019 | 257 | 0.140 |
Why?
|
| Social Class | 1 | 2018 | 73 | 0.130 |
Why?
|
| Disease Management | 1 | 2017 | 74 | 0.130 |
Why?
|
| Healthcare Disparities | 1 | 2017 | 43 | 0.130 |
Why?
|
| Genomics | 1 | 2018 | 109 | 0.130 |
Why?
|
| Health Status | 1 | 2017 | 111 | 0.130 |
Why?
|
| Urban Health | 1 | 2017 | 78 | 0.130 |
Why?
|
| Rural Health | 1 | 2017 | 118 | 0.130 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 262 | 0.110 |
Why?
|
| Capitation Fee | 1 | 2014 | 2 | 0.110 |
Why?
|
| Models, Economic | 1 | 2014 | 15 | 0.110 |
Why?
|
| Cholesterol, LDL | 3 | 2025 | 150 | 0.110 |
Why?
|
| Prospective Studies | 4 | 2023 | 1160 | 0.110 |
Why?
|
| Public Sector | 1 | 2014 | 82 | 0.100 |
Why?
|
| Macrophages | 1 | 2013 | 15 | 0.100 |
Why?
|
| Cholesterol | 1 | 2013 | 38 | 0.100 |
Why?
|
| Comorbidity | 3 | 2019 | 188 | 0.100 |
Why?
|
| Self Care | 1 | 2013 | 14 | 0.100 |
Why?
|
| Interviews as Topic | 3 | 2018 | 203 | 0.100 |
Why?
|
| Retrospective Studies | 2 | 2017 | 799 | 0.100 |
Why?
|
| Attitude to Health | 1 | 2013 | 56 | 0.100 |
Why?
|
| Blood Glucose Self-Monitoring | 2 | 2013 | 4 | 0.100 |
Why?
|
| Health Behavior | 1 | 2013 | 79 | 0.090 |
Why?
|
| Waist-Hip Ratio | 2 | 2025 | 29 | 0.090 |
Why?
|
| Acromegaly | 1 | 2011 | 1 | 0.090 |
Why?
|
| Somatotrophs | 1 | 2011 | 1 | 0.090 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 26 | 0.090 |
Why?
|
| Pennsylvania | 1 | 2010 | 1 | 0.090 |
Why?
|
| Kenya | 2 | 2023 | 183 | 0.090 |
Why?
|
| Sex Characteristics | 1 | 2010 | 43 | 0.080 |
Why?
|
| Models, Statistical | 1 | 2010 | 55 | 0.080 |
Why?
|
| Triglycerides | 2 | 2025 | 47 | 0.080 |
Why?
|
| Life Expectancy | 2 | 2023 | 31 | 0.080 |
Why?
|
| Ghana | 2 | 2021 | 67 | 0.080 |
Why?
|
| Cell Line | 2 | 2024 | 93 | 0.080 |
Why?
|
| Malawi | 2 | 2020 | 87 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 253 | 0.080 |
Why?
|
| Regression Analysis | 2 | 2020 | 133 | 0.080 |
Why?
|
| Age Factors | 2 | 2019 | 370 | 0.070 |
Why?
|
| Adolescent | 3 | 2019 | 2985 | 0.070 |
Why?
|
| Cholesterol, HDL | 2 | 2019 | 32 | 0.060 |
Why?
|
| Diet | 2 | 2020 | 109 | 0.060 |
Why?
|
| Mice | 2 | 2017 | 135 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 2024 | 14 | 0.060 |
Why?
|
| Waist Circumference | 1 | 2025 | 60 | 0.060 |
Why?
|
| Ankle Brachial Index | 1 | 2023 | 2 | 0.050 |
Why?
|
| Young Adult | 2 | 2021 | 2498 | 0.050 |
Why?
|
| Income | 1 | 2024 | 85 | 0.050 |
Why?
|
| Anti-Retroviral Agents | 2 | 2019 | 551 | 0.050 |
Why?
|
| Health Expenditures | 1 | 2024 | 39 | 0.050 |
Why?
|
| United Kingdom | 1 | 2023 | 33 | 0.050 |
Why?
|
| Longevity | 1 | 2023 | 14 | 0.050 |
Why?
|
| Antihypertensive Agents | 1 | 2023 | 64 | 0.050 |
Why?
|
| Urine Specimen Collection | 1 | 2022 | 6 | 0.050 |
Why?
|
| Incidence | 1 | 2025 | 685 | 0.050 |
Why?
|
| Potassium | 1 | 2022 | 25 | 0.050 |
Why?
|
| Animals | 2 | 2017 | 1081 | 0.050 |
Why?
|
| Infant | 2 | 2019 | 2244 | 0.050 |
Why?
|
| Metagenomics | 1 | 2022 | 13 | 0.050 |
Why?
|
| Hand Strength | 1 | 2021 | 7 | 0.050 |
Why?
|
| Electrocardiography | 1 | 2021 | 35 | 0.050 |
Why?
|
| Absorptiometry, Photon | 1 | 2021 | 85 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2021 | 41 | 0.040 |
Why?
|
| Echocardiography | 1 | 2021 | 100 | 0.040 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2021 | 65 | 0.040 |
Why?
|
| Bone Density | 1 | 2021 | 107 | 0.040 |
Why?
|
| Work | 1 | 2020 | 9 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2020 | 18 | 0.040 |
Why?
|
| Feces | 1 | 2020 | 30 | 0.040 |
Why?
|
| Bacteria | 1 | 2020 | 47 | 0.040 |
Why?
|
| Body Composition | 1 | 2021 | 153 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2020 | 179 | 0.040 |
Why?
|
| Patient Selection | 1 | 2020 | 40 | 0.040 |
Why?
|
| Quality Assurance, Health Care | 1 | 2020 | 43 | 0.040 |
Why?
|
| Multilevel Analysis | 1 | 2019 | 8 | 0.040 |
Why?
|
| Burkina Faso | 1 | 2019 | 29 | 0.040 |
Why?
|
| Uganda | 1 | 2020 | 197 | 0.040 |
Why?
|
| Biomarkers | 1 | 2020 | 327 | 0.040 |
Why?
|
| Linear Models | 1 | 2019 | 83 | 0.040 |
Why?
|
| Pregnancy | 1 | 2024 | 1862 | 0.040 |
Why?
|
| HIV | 1 | 2021 | 380 | 0.040 |
Why?
|
| Algorithms | 1 | 2019 | 106 | 0.040 |
Why?
|
| Research Design | 1 | 2020 | 124 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 217 | 0.040 |
Why?
|
| Diabetes Complications | 1 | 2018 | 15 | 0.040 |
Why?
|
| Mass Screening | 1 | 2020 | 245 | 0.040 |
Why?
|
| Healthy Lifestyle | 1 | 2018 | 9 | 0.030 |
Why?
|
| Morbidity | 1 | 2017 | 37 | 0.030 |
Why?
|
| Survival Rate | 1 | 2017 | 96 | 0.030 |
Why?
|
| Anthropometry | 1 | 2018 | 102 | 0.030 |
Why?
|
| Emigrants and Immigrants | 1 | 2017 | 11 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2017 | 89 | 0.030 |
Why?
|
| Body Weights and Measures | 1 | 2017 | 17 | 0.030 |
Why?
|
| Lipids | 1 | 2017 | 81 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2017 | 96 | 0.030 |
Why?
|
| Point-of-Care Systems | 1 | 2017 | 91 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2018 | 280 | 0.030 |
Why?
|
| Tuberculosis | 1 | 2020 | 543 | 0.030 |
Why?
|
| Viral Load | 1 | 2019 | 819 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2019 | 1748 | 0.030 |
Why?
|
| Private Sector | 1 | 2014 | 45 | 0.030 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2013 | 1 | 0.030 |
Why?
|
| Biological Transport | 1 | 2013 | 11 | 0.030 |
Why?
|
| Apolipoproteins B | 1 | 2013 | 13 | 0.030 |
Why?
|
| National Health Programs | 1 | 2014 | 78 | 0.030 |
Why?
|
| Kinetics | 1 | 2013 | 65 | 0.030 |
Why?
|
| Child | 1 | 2019 | 2242 | 0.030 |
Why?
|
| Culture | 1 | 2013 | 23 | 0.020 |
Why?
|
| HIV-1 | 1 | 2019 | 1260 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2013 | 563 | 0.020 |
Why?
|
| Anti-HIV Agents | 1 | 2017 | 1324 | 0.020 |
Why?
|
| Hypoglycemia | 1 | 2008 | 4 | 0.020 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2008 | 34 | 0.020 |
Why?
|
| Prognosis | 1 | 2008 | 199 | 0.020 |
Why?
|
| Quality of Life | 1 | 2008 | 177 | 0.020 |
Why?
|